Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
Plos One
|
January 18, 2013
Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: pre-approval validation study of the companion diagnostic test for vemurafenib
Fernando Lopez-Rios, Barbara Angulo, Belen Gomez, et al.
Cancer Letters
|
June 20, 2014
A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond
Carlos Gomez-Martín, Fernando Lopez-Rios, Jorge Aparicio, et al.
Cancer Treatment Reviews
|
May 11, 2024
NTRK gene fusion testing and management in lung cancer
Matteo Repetto, Marina Chiara Garassino, Herbert H Loong, et al.
ESMO Open
|
September 25, 2018
ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?
Florian Cabillic, Paul Hofman, Marius Ilie, et al.
Journal of Clinical Pathology
|
February 7, 2013
Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer
Fernando Lopez-Rios, Barbara Angulo, Belen Gomez, et al.
Histopathology
|
November 13, 2023
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists
Keith M Kerr, Lukas Bubendorf, Fernando Lopez-Rios, et al.
Molecular Cancer Therapeutics
|
June 11, 2009
Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts
Wells A Messersmith, N V Rajeshkumar, Aik Choon Tan, et al.
BMC Cancer
|
November 14, 2012
PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome
Purificacion Estevez-Garcia, Angel Castaño, Ana C Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2015
SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial
Manuel Hidalgo, Carlos Plaza, Monica Musteanu, et al.
Ebiomedicine
|
March 2, 2020
FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
Álvaro Quintanal-Villalonga, Irene Ferrer, Elizabeth Guruceaga, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
Plos One
|
January 18, 2013
Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: pre-approval validation study of the companion diagnostic test for vemurafenib
Fernando Lopez-Rios, Barbara Angulo, Belen Gomez, et al.
Cancer Letters
|
June 20, 2014
A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond
Carlos Gomez-Martín, Fernando Lopez-Rios, Jorge Aparicio, et al.
Cancer Treatment Reviews
|
May 11, 2024
NTRK gene fusion testing and management in lung cancer
Matteo Repetto, Marina Chiara Garassino, Herbert H Loong, et al.
ESMO Open
|
September 25, 2018
ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?
Florian Cabillic, Paul Hofman, Marius Ilie, et al.
Journal of Clinical Pathology
|
February 7, 2013
Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer
Fernando Lopez-Rios, Barbara Angulo, Belen Gomez, et al.
Histopathology
|
November 13, 2023
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists
Keith M Kerr, Lukas Bubendorf, Fernando Lopez-Rios, et al.
Molecular Cancer Therapeutics
|
June 11, 2009
Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts
Wells A Messersmith, N V Rajeshkumar, Aik Choon Tan, et al.
BMC Cancer
|
November 14, 2012
PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome
Purificacion Estevez-Garcia, Angel Castaño, Ana C Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2015
SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial
Manuel Hidalgo, Carlos Plaza, Monica Musteanu, et al.
Ebiomedicine
|
March 2, 2020
FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
Álvaro Quintanal-Villalonga, Irene Ferrer, Elizabeth Guruceaga, et al.
Page
of 7